MEI Pharma, Inc.

LSE:0JW9 Stock Report

Market Cap: US$15.7m

MEI Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0JW9?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders30,9740.465%
Institutions1,104,65916.6%
Hedge Funds1,704,62325.6%
General Public3,822,60157.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 42.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.4%
Anson Group
1,093,183US$2.6m0%0.34%
9.18%
Cable Car Capital LLC
611,440US$1.4m0%1.75%
5.79%
The Vanguard Group, Inc.
385,728US$910.3k-1.05%no data
2.07%
Renaissance Technologies LLC
137,646US$324.8k-5.26%no data
1.99%
Acadian Asset Management LLC
132,362US$312.4k-11.9%no data
1.02%
GreenWood Investors, LLC
67,733US$159.9k0%no data
1.01%
BlackRock, Inc.
67,260US$158.7k-9.92%no data
0.89%
Geode Capital Management, LLC
59,302US$140.0k15.6%no data
0.45%
Macquarie Investment Management Business Trust
29,999US$70.8k0%no data
0.4%
Bridgeway Capital Management, LLC
26,869US$63.4k0%no data
0.4%
National Bank Investments Inc.
26,512US$62.6k-19.7%no data
0.38%
World Investment Advisors, LLC
25,000US$59.0k0%no data
0.37%
Corsair Capital Management, L.P.
24,370US$57.5k0%0.01%
0.35%
Dimensional Fund Advisors LP
23,427US$55.3k41.4%no data
0.35%
Northern Trust Global Investments
23,035US$54.4k0%no data
0.27%
State Street Global Advisors, Inc.
17,821US$42.1k0%no data
0.2%
Susquehanna International Group, LLP, Asset Management Arm
13,378US$31.6k29.9%no data
0.19%
UBS Asset Management AG
12,878US$30.4k59%no data
0.16%
Squarepoint OPS LLC
10,728US$25.3k-38.8%no data
0.14%
Steven Wood
9,359US$22.1k115%no data
0.12%
James Flynn
7,900US$18.6k0%no data
0.11%
FNY Investment Advisers, LLC
7,010US$16.5k0%0.01%
0.087%
Morgan Stanley, Investment Banking and Brokerage Investments
5,828US$13.8k-0.51%no data
0.083%
Charles Baltic
5,555US$13.1k0%no data
0.037%
David Urso
2,464US$5.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MEI Pharma, Inc. is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen V. ByrneBofA Global Research
Jonathan AschoffBrean Capital
Gene MackBrean Capital